Dagmar is an international healthcare executive and entrepreneur, leading AQUILIA GROUP in healthcare facility planning, digital transformation, and strategic consulting. With a track record across EMEA, the USA, and APAC, she connects capital, solutions, and markets to advance human-centered industries and innovative technologies. Her focus lies in AI, the intersection of technology and operations, and global healthtech diplomacy.
Previously, she held senior leadership roles at global corporations, including the Fortune 500 company Fresenius VAMED, where she managed hospital networks and multi-million-euro healthcare projects on several continents. She has advised governments, institutions, and investors on innovative healthcare delivery models, public-private partnerships, and international expansion strategies.
Dagmar has completed executive programs at Harvard Business School and MIT Sloan, including AI in Healthcare. She also serves as a mentor for EmpowerUS, an initiative of the U.S. Department of Commerce, and sits on multiple boards and global initiatives as a strategic adviser.
Previously, she held senior leadership roles at global corporations, including the Fortune 500 company Fresenius VAMED, where she managed hospital networks and multi-million-euro healthcare projects on several continents. She has advised governments, institutions, and investors on innovative healthcare delivery models, public-private partnerships, and international expansion strategies.
Dagmar has completed executive programs at Harvard Business School and MIT Sloan, including AI in Healthcare. She also serves as a mentor for EmpowerUS, an initiative of the U.S. Department of Commerce, and sits on multiple boards and global initiatives as a strategic adviser.